Clinical Research Directory
Browse clinical research sites, groups, and studies.
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
Sponsor: Imperial College London
Summary
Endovenous interventions are keyhole operations for varicose veins that are carried out from within the vein itself. Varicose veins are enlarged veins close to the surface of the skin. They are connected to the bigger deeper veins in the leg (known as deep veins). Because of this, operations to close the varicose veins can increase the chance of a blood clot forming in the deep veins. Blood clots in the deep veins happen in around 1 in 50 people after endovenous operations. A clot in the leg can cause swelling, pain, and other long-term problems. If a clot in the leg breaks off and travels to the lungs, it can cause problems with the lung' ability to move oxygen from the air into the blood and may, in rare cases, be life threatening. Varicose vein procedures may carry a slightly higher risk of blood clot formation, and we are currently unsure if current clot reducing medicines are beneficial in preventing blood clots in people having varicose vein procedures. This study will investigate if it is worthwhile prescribing medicines to reduce blood clots after varicose vein procedures.
Official title: THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) - a Multi-centre Assessor-blind Randomised-controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
6660
Start Date
2024-01-22
Completion Date
2026-12-31
Last Updated
2025-05-02
Healthy Volunteers
No
Conditions
Interventions
Dalteparin Sodium
Low molecular weight heparin
Tinzaparin Sodium
Low molecular weight heparin
Enoxaparin Sodium
Low molecular weight heparin
Rivaroxaban
Direct oral anticoagulant
Apixaban
Direct oral anticoagulant
Dabigatran Etexilate
Direct oral anticoagulant
Locations (1)
Imperial College Hospital NHS Foundation Trust
London, United Kingdom